Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)

Thaci, D (author)

Pinter, A (author)

Sebastian, M (author)

Termeer, C (author)

Sticherling, M (author)

Gerdes, S (author)

Wegner, S (author)

Krampe, S (author)

Bartz, H (author)

Rausch, C (author)

Mensch, A (author)

(creator_code:org_t)

2020-01-20
2020
English.
In: The British journal of dermatology. - : Oxford University Press (OUP). - 1365-2133 .- 0007-0963. ; 183:2, s. 265-275

Related links:: https://onlinelibrar...; show more...; http://kipublication...; https://doi.org/10.1...; show less...

Subject headings

By the author/editor: Thaci, D; Pinter, A; Sebastian, M; Termeer, C; Sticherling, M; Gerdes, S; show more...; Wegner, S; Krampe, S; Bartz, H; Rausch, C; Mensch, A; Eyerich, K; show less...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.